400+
beds across our network
SEE OUR COVID-19 RESPONSE
40
principal investigators and
sub-investigators
ERG enjoys a proven track record of executing complex inpatient and outpatient clinical research trials in specialized populations and healthy volunteers across all age groups. We begin with industry-leading principal investigators with expertise in more than 50 specific indications. We back them with centralized operations that deliver consistent excellence across our sites. We offer clinical consulting services that provide a reliable resource in countering drug development challenges. Finally, we boast a robust database of more than 215,000 patients complemented by a centralized recruitment and marketing team, local community outreach programs and long-standing referral relationships. The result: Unparalleled support for sponsors and CROs in their quest to address our nation’s greatest unmet medical needs.
Differentiators
Single Point of Contact
Specialized Patient Recruitment
Complex and Early Phase Trials
Top Investigators
Spotlight
ERG Acquires Richmond Behavioral Associates
Evolution Research Group has acquired Staten Island, NY-based Richmond Behavioral Associates (“RBA”).
Introducing a new ERG logo
As we continue to grow, adding new sites and new capabilities, we have revised our logo. At its core: the people—patients, clinicians, customers—who are at the heart of everything we do.
New FibroScan® equipment at two ERG sites
ERG clinical research sites, Clinical Pharmacology of Miami and Endeavor Clinical Trials, have both installed FibroScan® equipment; they are actively screening patients to identify Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH).
Clients
